Australia's Hydration Pharmaceuticals soars on upbeat monthly sales

Hydration Pharmaceuticals

19/06/2025 06:20

** Shares of Hydration Pharmaceuticals HPC.AX rise 30% to A$0.013, their highest since February 10

** Hydration solutions co posts May net sales of US$308,000 vs US$280,000 last year

** Records monthly EBITDA loss of ~US$127,000, lowest in the CY

** Says progressing towards the positive EBITDA

** Stock on track for best day since May 2 if gains hold

** About 2.6 mln shares change hands, 4.8x the 30-day average of 546,440

** Stock down 27.8% YTD, including moves in current session

(Reporting by Jasmeen Ara Shaikh in Bengaluru)

((JasmeenAraIslam.Shaikh@thomsonreuters.com;))